Accendra Health (ACH) vs Sera Prognostics (SERA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sera Prognostics (SERA) has outperformed Accendra Health (ACH) over the past year, losing 36.3% versus a loss of 90.1%. Over five years, SERA leads with a -80.9% price change compared with -98.6% for ACH. Sera Prognostics is the larger company by market cap ($81.7 million vs $36.4 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | SERA |
|---|---|---|
| Share price | $0.4729 | $2.07 |
| Market cap | $36.37M | $81.66M |
| 1-day change | +1.46% | +0.98% |
| YTD return | -83.11% | -29.83% |
| 1-year return | -90.07% | -36.31% |
| 5-year return | -98.56% | -80.92% |
| Forward P/E | 5.18 | — |
| EPS (TTM) | $-1.44 | $-0.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $3.95 |
| 52-week low | $0.44 | $1.56 |
| Distance from 52-week high | -91.56% | -47.59% |
| Average volume | 1.39M | 28.59K |
| Shares outstanding | 76.90M | 38.48M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sera Prognostics is about 2.2 times larger than Accendra Health by market value ($81.66M vs $36.37M).
- SERA has outperformed ACH by 53.8 percentage points over the past year.
ACH vs SERA FAQ
Which is bigger, Accendra Health or Sera Prognostics?
Sera Prognostics (SERA) is larger, with a market capitalization of $81.66M compared with $36.37M for Accendra Health (ACH).
Which stock has performed better over the past year, ACH or SERA?
SERA returned -36.31% over the past 12 months, compared with -90.07% for ACH (price return, excluding dividends). Past performance does not predict future results.
Are Accendra Health and Sera Prognostics in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.